Controversies Surrounding IVF Treatments Persist in India

Written by Arushi Sharma

The landscape of IVF treatments in India is riddled with controversies. Unethical practices like manipulating donors and exploiting aspiring parents raise concerns about patient safety and underscore the need for stricter regulations.

Controversies Surrounding IVF Treatments Persist in India
India's in-vitro fertilization (IVF) sector faces criticism highlight the need for stricter rules, ethical practices, and improved oversight to ensure patient safety and well-being.

The landscape of in-vitro fertilization (IVF) treatments in India continues to be fraught with controversies, as recent cases highlight ongoing challenges and loopholes within the practice. Instances of manipulation, malpractices, and tragic consequences underscore the urgent need for stricter regulations and heightened awareness within the medical community and society at large.

One such case, dating back to 2012 in Mumbai, involved the death of an under-aged girl who donated her eggs at an infertility center using forged age documentation. Initially, doctors faced charges of murder, shedding light on the darker aspects of IVF procedures. Although eventually acquitted, similar incidents have surfaced across the country over the years, each with its own variations and complexities.

Manipulation within the IVF realm extends beyond donors to encompass IVF centers and practitioners. Recent reports from Varanasi highlight instances where aspiring mothers were duped by IVF specialists promising successful pregnancies through advanced techniques, only to face disappointment and financial loss.

The allure of the IVF market, projected to reach billions of dollars in revenue by 2030, serves as a breeding ground for unscrupulous actors seeking easy profits. The rush to capitalize on this lucrative industry has led to the proliferation of IVF centers nationwide, often without adequate planning or expertise.

Despite the passage of landmark acts by the Indian Parliament in 2021, including the Assisted Reproductive Technology (Regulation) Bill and the Surrogacy (Regulation) Bill, egregious incidents persist. These legislative measures were intended to safeguard women's reproductive rights and health while deterring illicit practices within the IVF sector. However, their effectiveness remains in question as cases of exploitation and misconduct continue to surface.

The toll of such controversies is far-reaching, impacting not only the victims directly involved but also the reputation and integrity of the medical profession as a whole. As the demand for IVF treatments grows, the need for comprehensive safeguards, transparent practices, and stringent enforcement mechanisms becomes increasingly urgent.

Efforts to address these challenges must involve all stakeholders, including policymakers, law enforcement agencies, medical professionals, and the public. Enhanced education, robust donor screening protocols, centralized health data systems, and a culture of accountability are essential components of a sustainable and ethical IVF landscape.

As India grapples with the complexities of IVF treatments, the imperative to uphold ethical standards and prioritize patient well-being remains paramount. Only through concerted action and unwavering commitment can the promise of assisted reproductive technology be realized without compromising on ethics or integrity.

Share article